Evidence map›Paper›PMID 21574244›Full record

ArticleAmerican journal of medical genetics. Part A2011

Genomic strategy identifies a missense mutation in WD-repeat domain 65 (WDR65) in an individual with Van der Woude syndrome.

Nicholas K Rorick, Akira Kinoshita, Jason L Weirather, Myriam Peyrard-Janvid, Renata L L Ferreira de Lima, Martine Dunnwald, Alan L Shanske, Danilo Moretti-Ferreira, Hannele Koillinen, Juha Kere and 4 more

Open access · greenAbstract read
In one paragraph

Article in American journal of medical genetics. Part A, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Hemocyte Clusters Defined by scRNA-Seq inFrontiers in immunology · 2022
    Article
  3. AnDevelopment (Cambridge, England) · 2020
    Article
  4. Article
  5. Article
  6. The prevalence, penetrance, and expressivity of etiologicMolecular genetics & genomic medicine · 2017
    Article
  7. Article
  8. Article
  9. Article
  10. Transcriptional targeting in the airway using novel gene regulatory elements.American journal of respiratory cell and molecular biology · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 4 countries.

Nicholas K RorickDepartment of Pediatrics, University of Iowa, Iowa City, USA.
Akira Kinoshita
Jason L Weirather
Myriam Peyrard-Janvid
Renata L L Ferreira de Lima
Martine Dunnwald
Alan L Shanske
Danilo Moretti-Ferreira
Hannele Koillinen
Juha Kere
Maria A Mansilla
Jeffrey C Murray
Steve L Goudy
Brian C Schutte
University of Iowa · USKarolinska Institutet · SEChildren's Hospital at Montefiore · USMichigan State University · USTurku University Hospital · FIUniversidade Estadual Paulista (Unesp) · BRUniversidade Federal da Bahia · BRVanderbilt University · US

Funding

PHENOTYPE AND GENETICS IN OROFACIAL CLEFT FAMILIESP50DE016215 · NIDCR · UNIVERSITY OF IOWA · PI LOVETT, MICHAEL · 2004 to 2008
$10.1M
Molecular Genetic Epidemiology of Cleft Lip and PalateR37DE008559 · NIDCR · UNIVERSITY OF IOWA · PI MURRAY, JEFFREY C · 2004 to 2013
$6.8M
PREDOCTORAL TRAINING PROGRAM IN GENETICST32GM008629 · NIGMS · UNIVERSITY OF IOWA · PI EBERL, DANIEL F · 1997 to 2021
$4.1M
CLONING AND CHARACTERIZATION OF THE VAN DER WOUDE GENER01DE013513 · NIDCR · UNIVERSITY OF IOWA · PI SCHUTTE, BRIAN C · 2000 to 2009
$2.6M
MOLECULAR GENETIC EPIDEMIOLOGY OF CLEFT LIP AND PALATER01DE008559 · NIDCR · UNIVERSITY OF IOWA · PI MURRAY, JEFFREY C · 1988 to 2003
$1.5M
NIDCR NIH HHS DE08559NIDCR NIH HHS DE13513NIDCR NIH HHS DE16215NIDCR NIH HHS P50 DE016215NIDCR NIH HHS R01 DE008559NIDCR NIH HHS R01 DE013513NIDCR NIH HHS R37 DE008559NIGMS NIH HHS 5 T32 GM08629NIGMS NIH HHS T32 GM008629
6 · The paper itself

Abstract

Genetic variation in the transcription factor interferon regulatory factor 6 (IRF6) causes and contributes risk for oral clefting disorders. We hypothesized that genes regulated by IRF6 are also involved in oral clefting disorders. We used five criteria to identify potential IRF6 target genes; differential gene expression in skin taken from wild-type and Irf6-deficient murine embryos, localization to the Van der Woude syndrome 2 (VWS2) locus at 1p36-1p32, overlapping expression with Irf6, presence of a conserved predicted-binding site in the promoter region, and a mutant murine phenotype that was similar to the Irf6 mutant mouse. Previously, we observed altered expression for 573 genes; 13 were located in the murine region syntenic to the VWS2 locus. Two of these genes, Wdr65 and Stratifin, met 4 of 5 criteria. Wdr65 was a novel gene that encoded a predicted protein of 1,250 amino acids with two WD domains. As potential targets for Irf6 regulation, we hypothesized that disease-causing mutations will be found in WDR65 and Stratifin in individuals with VWS or VWS-like syndromes. We identified a potentially etiologic missense mutation in WDR65 in a person with VWS who does not have an exonic mutation in IRF6. The expression and mutation data were consistent with the hypothesis that WDR65 was a novel gene involved in oral clefting.

Indexed as

Abnormalities, MultipleAnimalsBase SequenceChromosomes, Human, Pair 1Cleft LipCleft PalateCloning, MolecularComputational BiologyCystsDNA, ComplementaryGene Expression RegulationHumansIn Situ HybridizationInterferon Regulatory FactorsLipMiceCFAP57 protein, humanDNA, ComplementaryInterferon Regulatory FactorsIRF6 protein, humanMicrotubule-Associated ProteinsProteins

Identifiers

PMID21574244
PMCPMC3753799
OpenAlexW2135559648

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.